이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Tien Liang BioTech 대차 대조표 상태
재무 상태 기준 확인 6/6
Tien Liang BioTech has a total shareholder equity of NT$500.5M and total debt of NT$70.0M, which brings its debt-to-equity ratio to 14%. Its total assets and total liabilities are NT$656.4M and NT$155.9M respectively. Tien Liang BioTech's EBIT is NT$19.6M making its interest coverage ratio 14.1. It has cash and short-term investments of NT$170.6M.
주요 정보
14.0%
부채 비율
NT$70.00m
부채
| 이자 보상 비율 | 14.1x |
| 현금 | NT$170.58m |
| 주식 | NT$500.54m |
| 총 부채 | NT$155.90m |
| 총 자산 | NT$656.44m |
재무 상태 분석
단기부채: 4127's short term assets (NT$313.8M) exceed its short term liabilities (NT$139.6M).
장기 부채: 4127's short term assets (NT$313.8M) exceed its long term liabilities (NT$16.3M).
부채 대 자본 내역 및 분석
부채 수준: 4127 has more cash than its total debt.
부채 감소: 4127's debt to equity ratio has reduced from 32% to 14% over the past 5 years.
부채 범위: 4127's debt is well covered by operating cash flow (162.2%).
이자 보장: 4127's interest payments on its debt are well covered by EBIT (14.1x coverage).